| Trial registration number
|
NCT04682574 |
Full text link
Last imported at : Dec. 25, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT04682574
|
First author
Last imported at : May 8, 2022, 5:30 a.m.
Source : ClinicalTrials.gov
|
Muhammad Mansoor Hafeez
|
Contact
Last imported at : May 8, 2022, 5:30 a.m.
Source : ClinicalTrials.gov
|
not reported
|
Registration date
Last imported at : Dec. 25, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
2020-12-23
|
Recruitment status
Last imported at : May 8, 2022, 5:30 a.m.
Source : ClinicalTrials.gov
|
Completed
|
Study design
Last imported at : Dec. 25, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : Dec. 25, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : Dec. 25, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : May 8, 2022, 5:30 a.m.
Source : ClinicalTrials.gov
|
Blind label
|
Center
Last imported at : Dec. 25, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : Dec. 25, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Treatment
|
Inclusion criteria
Last imported at : Dec. 25, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
critically ill patients admitted in icu
|
Exclusion criteria
Last imported at : Dec. 25, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
allergic to vitamin c didnt given the consent
|
Number of arms
Last imported at : Dec. 25, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : Dec. 25, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
University of Lahore
|
Inclusion age min
Last imported at : Dec. 25, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
2
|
Inclusion age max
Last imported at : Dec. 25, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
100
|
Countries
Last imported at : Dec. 25, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Pakistan
|
Type of patients
Last imported at : Dec. 25, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
Critical disease at enrollment
|
Severity scale
Last imported at : Dec. 25, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
8: Critical disease at enrollment
|
Total sample size
Last imported at : May 8, 2022, 5:30 a.m.
Source : ClinicalTrials.gov
|
278
|
primary outcome
Last imported at : May 8, 2022, 5:30 a.m.
Source : ClinicalTrials.gov
|
Partial pressure of Oxygen in arterial blood to fraction of inspired Oxygen (P/F ratio);Survival analysis
|
Notes
Last imported at : Dec. 25, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
Not reported
|
Arms
Last imported at : Dec. 30, 2020, 12:31 a.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "", "treatment_id": 1369, "treatment_name": "Vitamin c", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|